Literature DB >> 7769140

In vivo activity and in vitro specificity of CD4+ Th1 and Th2 cells derived from the spleens of diabetic NOD mice.

D Healey1, P Ozegbe, S Arden, P Chandler, J Hutton, A Cooke.   

Abstract

CD4+ T cell lines were generated from the spleens of diabetic NOD mice against crude membrane preparations derived from a rat insulinoma. Adoptive transfer of these lines into neonatal mice confirms that overt diabetes is induced by gamma-IFN-secreting Th1 cells, whereas transfer of IL-4-secreting Th2 cells resulted in a nondestructive peri-islet insulitis. Analysis of the antigens recognized by individual T cell clones from the Th1 line included reactivity against an insulinoma membrane fraction enriched in proteins of approximately 38 kD. Immune responses to the same antigen preparation have been associated with T cell clones derived from human insulin-dependent diabetes mellitus. The specificity of Th2 cells includes reactivity to a fraction enriched in proteins of 30 kD. The data suggest that in insulin-dependent diabetes mellitus the balance between beta cell destruction, associated with intra-islet infiltration, and nondestructive (potential protective) peri-islet insulitis may depend on both the antigens recognized, and the prevailing cytokine environment.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7769140      PMCID: PMC295987          DOI: 10.1172/JCI118006

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  32 in total

1.  In-vivo anti-CD3 treatment of autoimmune patients.

Authors:  L Chatenoud; C Ferran; J F Bach
Journal:  Lancet       Date:  1989-07-15       Impact factor: 79.321

2.  Anti-suppressor effect of cyclophosphamide on the development of spontaneous diabetes in NOD mice.

Authors:  R Yasunami; J F Bach
Journal:  Eur J Immunol       Date:  1988-03       Impact factor: 5.532

3.  Immunotherapy of the nonobese diabetic mouse: treatment with an antibody to T-helper lymphocytes.

Authors:  J A Shizuru; C Taylor-Edwards; B A Banks; A K Gregory; C G Fathman
Journal:  Science       Date:  1988-04-29       Impact factor: 47.728

4.  Isolation and characterisation of insulin secretory granules from a rat islet cell tumour.

Authors:  J C Hutton; E J Penn; M Peshavaria
Journal:  Diabetologia       Date:  1982-10       Impact factor: 10.122

5.  Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse.

Authors:  K J Pennline; E Roque-Gaffney; M Monahan
Journal:  Clin Immunol Immunopathol       Date:  1994-05

6.  Insulin secretion by a transplantable rat islet cell tumour.

Authors:  A M Sopwith; J C Hutton; S P Naber; W L Chick; C N Hales
Journal:  Diabetologia       Date:  1981-09       Impact factor: 10.122

7.  A transplantable insulinoma in the rat.

Authors:  W L Chick; S Warren; R N Chute; A A Like; V Lauris; K C Kitchen
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

8.  Suppression of overt diabetes in NOD mice by anti-thymocyte serum or anti-Thy 1, 2 antibody.

Authors:  M Harada; S Makino
Journal:  Jikken Dobutsu       Date:  1986-10

9.  Cyclosporin increases the rate and length of remissions in insulin-dependent diabetes of recent onset. Results of a multicentre double-blind trial.

Authors:  G Feutren; L Papoz; R Assan; B Vialettes; G Karsenty; P Vexiau; H Du Rostu; M Rodier; J Sirmai; A Lallemand
Journal:  Lancet       Date:  1986-07-19       Impact factor: 79.321

10.  T cell-mediated inhibition of the transfer of autoimmune diabetes in NOD mice.

Authors:  C Boitard; R Yasunami; M Dardenne; J F Bach
Journal:  J Exp Med       Date:  1989-05-01       Impact factor: 14.307

View more
  26 in total

Review 1.  Type I (insulin-dependent) diabetes is a Th1- and Th2-mediated autoimmune disease.

Authors:  S T Azar; H Tamim; H N Beyhum; M Z Habbal; W Y Almawi
Journal:  Clin Diagn Lab Immunol       Date:  1999-05

2.  The pathogenicity of islet-infiltrating lymphocytes in the non-obese diabetic (NOD) mouse.

Authors:  V Ablamunits; D Elias; I R Cohen
Journal:  Clin Exp Immunol       Date:  1999-02       Impact factor: 4.330

3.  Anti-IL-7 receptor-α reverses established type 1 diabetes in nonobese diabetic mice by modulating effector T-cell function.

Authors:  Li-Fen Lee; Kathryn Logronio; Guang Huan Tu; Wenwu Zhai; Irene Ni; Li Mei; Jeanette Dilley; Jessica Yu; Arvind Rajpal; Colleen Brown; Charles Appah; Sherman Michael Chin; Bora Han; Timothy Affolter; John C Lin
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-25       Impact factor: 11.205

4.  OdDHL inhibits T cell subset differentiation and delays diabetes onset in NOD mice.

Authors:  Wendy Gaisford; David I Pritchard; Anne Cooke
Journal:  Clin Vaccine Immunol       Date:  2011-06-08

5.  Absence of significant Th2 response in diabetes-prone non-obese diabetic (NOD) mice.

Authors:  A Hartemann-Heurtier; M F Richard; C Boitard
Journal:  Clin Exp Immunol       Date:  1999-05       Impact factor: 4.330

6.  Beta2-glycoprotein I-dependent and -independent anticardiolipin antibody in non-obese diabetic (NOD) mice.

Authors:  K Anzai; S Nagafuchi; Y Niho; M Kikuchi; J Ono
Journal:  Clin Exp Immunol       Date:  1998-01       Impact factor: 4.330

7.  Suppression of autoimmune diabetes by soluble galectin-1.

Authors:  Marcelo J Perone; Suzanne Bertera; William J Shufesky; Sherrie J Divito; Angela Montecalvo; Alicia R Mathers; Adriana T Larregina; Mabel Pang; Nilufer Seth; Kai W Wucherpfennig; Massimo Trucco; Linda G Baum; Adrian E Morelli
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

8.  Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice.

Authors:  David Bending; Hugo De la Peña; Marc Veldhoen; Jenny M Phillips; Catherine Uyttenhove; Brigitta Stockinger; Anne Cooke
Journal:  J Clin Invest       Date:  2009-02-02       Impact factor: 14.808

9.  B lymphocyte "original sin" in the bone marrow enhances islet autoreactivity in type 1 diabetes-prone nonobese diabetic mice.

Authors:  Rachel A Henry-Bonami; Jonathan M Williams; Amita B Rachakonda; Mariam Karamali; Peggy L Kendall; James W Thomas
Journal:  J Immunol       Date:  2013-05-15       Impact factor: 5.422

10.  Imogen 38: a novel 38-kD islet mitochondrial autoantigen recognized by T cells from a newly diagnosed type 1 diabetic patient.

Authors:  S D Arden; B O Roep; P I Neophytou; E F Usac; G Duinkerken; R R de Vries; J C Hutton
Journal:  J Clin Invest       Date:  1996-01-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.